Author:
Cai Xuzi,Shi Si,Chen Gui,Zhong Min,Yang Yuanyuan,Mai Ziyi,Tian Yang,Tan Jinxiu,He Lijuan,Cui Chunhui,Yu Zhiqiang,Wang Xuefeng
Subject
Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology
Reference62 articles.
1. Metastatic gynecologic malignancies: advances in treatment and management;Chan;Clin. Exp. Metastasis,2018
2. A source of hope for platinum-resistant ovarian cancer?;Blagden;Lancet,2021
3. Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness;Muñoz-Galván;Mol. Cancer,2020
4. Phase Ib study of navicixizumab plus paclitaxel in patients with platinum-resistant ovarian, primary peritoneal, or fallopian tube cancer;Fu;J. Clin. Oncol.,2022
5. Fuzuloparib maintenance therapy in patients with platinum-sensitive, recurrent ovarian carcinoma (FZOCUS-2): a multicenter, randomized, double-blind, placebo-controlled, phase III trial;Li;J. Clin. Oncol.,2022
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献